Pyroptosis, a programmed cell death mediated by the Gasdermin (GSDM) family (1, 2) of proteins, has become a therapeutic target for various diseases, including cancer (3), infectious diseases (4), metabolic disorders (5), and neural-related diseases (6). This evidence concerns the gene GSDMA and metabolic disease.